Literature DB >> 9819571

How the osteoclast degrades bone.

H C Blair1.   

Abstract

Osteoclasts are multinucleated monocyte-macrophage derivatives that degrade bone. Their specialized role is central to a process that continuously removes and replaces segments of the skeleton in the higher vertebrates. Osteoclasts allow skeletal mineral to be used to manage extracellular calcium activity, which is an important adaptation for life on land, and solid skeletal structure to be replaced by hollow architecture that has a superior strength-to-weight ratio. Degrading bone also allows periodic repair and remodeling for ordered growth and efficient response to mechanical loads. A fairly comprehensive view of osteoclastic ontogeny and function is emerging from recent studies. Osteoclasts dissolve bone mineral by massive acid secretion and secrete specialized proteinases that degrade the organic matrix, mainly type I collagen, in this acidic milieu. The site of bone dissolution is a high-calcium environment; removal of degradation products by transcytosis of membrane vesicles allows the osteoclast to maintain a normal intracellular calcium. Osteoclastic differentiation is normally balanced with bone formation, although bone formation is the function of unrelated stromal cell-derived osteoblasts. Interactions between osteoclast precursors and bone-forming cells are believed to control osteoclast differentiation under most circumstances, preserving bone architecture over many cycles of bone replacement.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9819571     DOI: 10.1002/(SICI)1521-1878(199810)20:10<837::AID-BIES9>3.0.CO;2-D

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  35 in total

Review 1.  Latent-TGF-beta: an overview.

Authors:  D A Lawrence
Journal:  Mol Cell Biochem       Date:  2001-03       Impact factor: 3.396

2.  Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification.

Authors:  Susan A Steitz; Mei Y Speer; Marc D McKee; Lucy Liaw; Manuela Almeida; Hsueh Yang; Cecilia M Giachelli
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

3.  Nano-topography sensing by osteoclasts.

Authors:  Dafna Geblinger; Lia Addadi; Benjamin Geiger
Journal:  J Cell Sci       Date:  2010-04-07       Impact factor: 5.285

4.  Bioceramics composition modulate resorption of human osteoclasts.

Authors:  Y Ramaswamy; D R Haynes; G Berger; R Gildenhaar; H Lucas; C Holding; H Zreiqat
Journal:  J Mater Sci Mater Med       Date:  2005-12       Impact factor: 3.896

5.  AcidoCEST-UTE MRI for the Assessment of Extracellular pH of Joint Tissues at 3 T.

Authors:  Ya-Jun Ma; Rachel A High; Qingbo Tang; Lidi Wan; Saeed Jerban; Jiang Du; Eric Y Chang
Journal:  Invest Radiol       Date:  2019-09       Impact factor: 6.016

6.  Resorption behavior of a nanostructured bone substitute: in vitro investigation and clinical application.

Authors:  Christoph Reichert; Werner Götz; Susanne Reimann; Ludger Keilig; Martin Hagner; Christoph Bourauel; Andreas Jäger
Journal:  J Orofac Orthop       Date:  2013-03-08       Impact factor: 1.938

7.  Cancer pain physiology.

Authors:  Sarah Falk; Kirsty Bannister; Anthony H Dickenson
Journal:  Br J Pain       Date:  2014-11

Review 8.  Skeletal complications in cancer patients with bone metastases.

Authors:  Shunsuke Tsuzuki; Sun Hee Park; Matthew R Eber; Christopher M Peters; Yusuke Shiozawa
Journal:  Int J Urol       Date:  2016-08-03       Impact factor: 3.369

9.  Gallium modulates osteoclastic bone resorption in vitro without affecting osteoblasts.

Authors:  Elise Verron; Martial Masson; Solmaz Khoshniat; Laurence Duplomb; Yohann Wittrant; Marc Baud'huin; Zahi Badran; Bruno Bujoli; Pascal Janvier; Jean-Claude Scimeca; Jean-Michel Bouler; Jérôme Guicheux
Journal:  Br J Pharmacol       Date:  2010-04       Impact factor: 8.739

Review 10.  Interaction of staphylococci with bone.

Authors:  John A Wright; Sean P Nair
Journal:  Int J Med Microbiol       Date:  2009-11-03       Impact factor: 3.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.